Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Postoperative abdominal sepsis induces selective and persistent changes in CTCF binding within the MHC-II region of human monocytes. | PLoS One | 2021 | 33939725 | PubTator, text mining | PubMed |
| An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens. | Front Immunol | 2021 | 33936100 | PubTator, text mining | PubMed |
| IFNγ, and to a Lesser Extent TNFα, Provokes a Sustained Endothelial Costimulatory Phenotype. | Front Immunol | 2021 | 33936069 | PubTator, text mining | PubMed |
| Immuno-oncology for B-cell lymphomas. | Blood Res | 2021 | 33935038 | PubTator, text mining | PubMed |
| Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets. | J Allergy Clin Immunol | 2021 | 33932468 | PubTator, text mining | PubMed |
| Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration. | Front Pharmacol | 2021 | 33927630 | PubTator, text mining | PubMed |
| Nod-Like Receptors in Host Defence and Disease at the Epidermal Barrier. | Int J Mol Sci | 2021 | 33925158 | PubTator, text mining | PubMed |
| Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of Cancer. | Cancers (Basel) | 2021 | 33923528 | PubTator, text mining | PubMed |
| Integrative Analysis of miRNA and mRNA Expression Profiles in Mammary Glands of Holstein Cows Artificially Infected with Staphylococcus aureus. | Pathogens | 2021 | 33922375 | PubTator, text mining | PubMed |
| Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets. | Cancers (Basel) | 2021 | 33918793 | PubTator, text mining | PubMed |
| Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. | Pharmaceutics | 2021 | 33918207 | PubTator, text mining | PubMed |
| Roles of Inflammasomes in Epstein-Barr Virus-Associated Nasopharyngeal Cancer. | Cancers (Basel) | 2021 | 33918087 | PubTator, text mining | PubMed |
| Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation. | Int J Mol Sci | 2021 | 33917174 | PubTator, text mining | PubMed |
| Positive natural selection in primate genes of the type I interferon response. | BMC Ecol Evol | 2021 | 33902453 | PubTator, text mining | PubMed |
| Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity. | Front Immunol | 2021 | 33897711 | PubTator, text mining | PubMed |
| Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma. | Hepatology | 2021 | 33896016 | PubTator, text mining | PubMed |
| Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions. | Front Oncol | 2021 | 33869061 | PubTator, text mining | PubMed |
| Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery. | Cancer Immunol Immunother | 2021 | 33866408 | PubTator, text mining | PubMed |
| The Murine MHC Class II Super Enhancer IA/IE-SE Contains a Functionally Redundant CTCF-Binding Component and a Novel Element Critical for Maximal Expression. | J Immunol | 2021 | 33863790 | PubTator, text mining | PubMed |
| Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential. | Front Immunol | 2021 | 33859645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=59